System Raises $20 Million To Build Vertically Integrated Peptide Platform As Market Reaches $163 Billion
By Amit Chowdhry ● Sep 9, 2026
System has raised $20 million in new funding to expand its vertically integrated peptide platform, which connects patients with licensed U.S. clinicians and pharmacy-compounded treatments as the company targets a global peptide therapeutics market estimated at $163 billion in 2026. The financing includes Patron Fund, Vine, Courtside, Daybreak, SV Angel and Will Ventures. System plans to use the capital to broaden access to its platform and continue building infrastructure across the peptide supply chain.